<h1 id="intravenous-fluid-formulations-and-chloride-restrictive-iv-fluids-for-icu-patients">Intravenous Fluid Formulations and Chloride-Restrictive IV Fluids for ICU Patients</h1>
<table>
<thead>
<tr>
<th>Content per 1 L</th>
<th>Lactated Ringer&#39;s</th>
<th>Normal Saline (0.9%)</th>
<th>Plasma-Lyte 148</th>
<th>D5W</th>
<th>D5 1/2NS</th>
<th>5% albumin</th>
</tr>
</thead>
<tbody>
<tr>
<td>Na (mEq)</td>
<td>130</td>
<td>154</td>
<td>140</td>
<td></td>
<td>77</td>
<td>130-160</td>
</tr>
<tr>
<td>K (mEq)</td>
<td>4</td>
<td></td>
<td>5</td>
<td></td>
<td></td>
<td>&lt; 1</td>
</tr>
<tr>
<td>Cl (mEq)</td>
<td>109</td>
<td>154</td>
<td>98</td>
<td></td>
<td>77</td>
<td>130-160</td>
</tr>
<tr>
<td>Ca (mEq)</td>
<td>3</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Mg (mEq)</td>
<td></td>
<td></td>
<td>3</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Lactate (mEq)</td>
<td>28</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Acetate (mEq</td>
<td></td>
<td></td>
<td>27</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Gluconate (mEq)</td>
<td></td>
<td></td>
<td>23</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Glucose (mg/dL)</td>
<td></td>
<td></td>
<td></td>
<td>4545</td>
<td>4545</td>
<td></td>
</tr>
<tr>
<td>Osmolarity (mOsm/L)</td>
<td>273</td>
<td>308</td>
<td>294</td>
<td>252</td>
<td>406</td>
<td>309</td>
</tr>
<tr>
<td>pH</td>
<td>6.5</td>
<td>5.0</td>
<td>5.0</td>
<td>4.0</td>
<td>4.5</td>
<td>6.4-7.4</td>
</tr>
<tr>
<td>Other</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>50 g/L  albumin</td>
</tr>
</tbody>
</table>
<p><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=23073953">Yunos et al JAMA 2012 study:</a></p>
<ul>
<li>Prospective open, label sequential study of 760 ICU patients (control) and 773 ICU patients (study group) at single hospital in Melbourne, Australia</li>
<li>Control period: Standard IVF per physician preference</li>
<li>Study period: Chloride-rich IVF (0.9% saline, 4% succinylated gelatin solution, 4% albumin) became restricted and required specialist approval. Standard fluids allowed were chloride-restrictive fluids (Hartmann solution – similar to lactated ringer’s, Plasma-Lyte 148, chloride-poor 20% albumin)</li>
</ul>
<table>
<thead>
<tr>
<th></th>
<th>Control period (Chloride-liberal)</th>
<th>Study period (Chloride-restricted)</th>
<th>P value</th>
<th>Odds ratio for Cl-restrictive  fluid use</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mean serum Cr increased in umol/L</td>
<td>22.6 (0.26 mg/dL)</td>
<td>14.8 (0.17 mg/dL)</td>
<td>0.3</td>
<td></td>
</tr>
<tr>
<td>Incidence of injury &amp; failure class for &quot;acute kidney injury&quot; (RIFLE defn)</td>
<td>14%</td>
<td>8.4%</td>
<td>&lt;0.001</td>
<td>0.52</td>
</tr>
<tr>
<td>Use of renal replacement therapy (RRT)</td>
<td>10%</td>
<td>6.3%</td>
<td>0.005</td>
<td>0.52</td>
</tr>
</tbody>
</table>
<p><strong>Bottom line:</strong> Chloride-rich IV fluids were associated w/ greater acute kidney injury and need for RRT in ICU patients, compared to chloride-restrictive IV fluids. </p>
<p><strong>NOTE:</strong> There was, however, NO difference in mortality, hospital, ICU length of stay, or RRT after hospital discharge.</p>
<h2 id="references">References</h2>
<ul>
<li><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=23073953">Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012 Oct 17;308(15):1566-72. doi: 10.1001/jama.2012.13356.</a></li>
<li><a href="http://www.medscape.org/viewarticle/503138%20">http://www.medscape.org/viewarticle/503138</a></li>
</ul>
